Ethyl 4,6-dichloronicotinate
CAS: 40296-46-6
Ref. 3D-FE33985
5g | 136,00 € | ||
10g | 197,00 € | ||
25g | 281,00 € | ||
50g | 440,00 € | ||
100g | 626,00 € |
Informação sobre produto
- 4,6-Dichloropyridine-3-Carboxylic Acid Ethyl Ester
- 4,6-Dichloronicotinic Acid Ethyl Ester
- Ethyl 4,6-Dichloronicotinate
- 2,4-Dichloro-5-carbethoxypyridine
- 4,6-Dichloronicotinic acid ethyl ester ,97%
- Ethyl 4,6-Dichloropyridine-3-Carboxylate
Ethyl 4,6-dichloronicotinate (EDCN) is a hybrid drug that can be used as a clinical drug for the treatment of cancers. EDCN has been shown to have an antiproliferative effect in hematopoietic cells and tumor cells. It is also able to inhibit tyrosine kinase activity and cellular proliferation by inducing apoptosis. EDCN has been shown to be a potent inhibitor of cancer cell growth in vitro and in vivo, with IC50 values ranging from 1 to 10 μM. This drug is active against leukemia, lymphoma, breast cancer, prostate cancer, colorectal cancer, and other cancers that are sensitive to inhibition by tyrosine kinase inhibitors. EDCN binds reversibly to DNA with high affinity and specificity through hydrogen bonding interactions between the nucleobases on its aromatic ring system and the purine bases on dsDNA. This binding inhibits transcription by blocking access of RNA polymerase II to DNA templates
Propriedades químicas
Consulta técnica sobre: 3D-FE33985 Ethyl 4,6-dichloronicotinate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.